Skip to main content
Clinical Trials/NCT03815994
NCT03815994SuspendedNot Applicable

Effects of Physical Therapy With Neuromuscular Electrical Stimulation in Critically Ill Patients: a Randomised Crossover Clinical Trial Protocol.

University of Sao Paulo1 site in 1 country31 target enrollmentStarted: November 13, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Suspended
Enrollment
31
Locations
1
Primary Endpoint
Change of Oxygen consumption (VO2),from baseline and interventions.

Study Overview

Brief Summary

The study will investigate the effects of neuromuscular electrical stimulation (NMES) in critically ill patients. The objective of this study will be investigate the effects of neuromuscular electrical stimulation (NMES) in critically ill patients.

Detailed Description

The study will investigate the effects of neuromuscular electrical stimulation (NMES) in critically ill patients. It will be a randomised crossover clinical trial. Thirty-one patients will enrolled. Patients will be selected, randomly, to the intervention Protocol (decubitus position with the limbs raised and NMES) and control (decubitus position with the limbs raised without NMES).The patients will be allocated in Group 1 (intervention and control) or group 2 (control and intervention) with a wash-out period of 4 to 6 hours between them.

The main outcome will be metabolic data. Linear mixed model will be used for analysis of dependent variables and estimated values of the mean of the differences of each effect.

The results of this study will allow better understanding of the metabolic effects of NMES in patients critically ill.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Supportive Care
Masking
Single (Investigator)

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •All patients that will be admitted to the intensive care unit
  • •Hemodynamic stability
  • •Mechanical ventilation.

Exclusion Criteria

  • •In general:
  • •a. Pregnant women
  • •b. Brain death
  • •c. Neuromuscular diseases
  • •d. Use of pre-existing neuromuscular blocker in the last 24 hours, prior to the study protocol.
  • •Contraindications for the use of NMES:
  • •a. Fractures
  • •c. Skin lesions
  • •d. Systemic vascular impairment diseases such as systemic lupus erythematosus, thromboembolic disease, deep vein thrombosis (which was not therapeutically anticoagulated for a time greater than 36 hours)
  • •e. Lower limb amputations
  • •f. Cardiac pacemaker,
  • •g. Thrombocytopenia less than 20,000/mm3
  • •h. BMI greater than 35 kg/m2
  • •i. Important lower extremity oedema
  • •j. Agitation and/or signs of pain during the electrical stimulation.
  • •Contraindications to begin or continue NMES procedure:
  • •a. Mean arterial blood pressure less than 65 mmHg
  • •b. Use of vasopressor >50% of themaximum dose (dopamine >12.5 μg/kg per minute; vasopressin >0.02U/min and norepinephrine >1 μg/kg per minute),
  • •c. Heart rate <50 or >140bpm
  • •d. Arrhythmias with hemodynamic consequences
  • •e. Myocardial ischemia,
  • •f. Temperature <34 or >39oC
  • •g. Intracranial pressure >20 cmH2O
  • •h. Decrease in 10% of SpO2 baseline value or <88% for more than one minute.

Arms & Interventions

Experimental: group 1

Experimental

Neuromuscular Electrical Stimulation (NMES) and after decubitus position with the limbs raised without NMES.

Intervention: Neuromuscular Electrical Stimulation (Device)

group 2

Sham Comparator

Decubitus Position with the limbs raised withou tNeuromuscular Electrical Stimulation and after Neuromuscular Electrical Stimulation.

Intervention: Neuromuscular Electrical Stimulation (Device)

Outcomes

Primary Outcomes

Change of Oxygen consumption (VO2),from baseline and interventions.

Time Frame: VO2 will be taken during the each intervention, it will be taken only the first day

Change of Oxygen consumption (VO2) will be evaluated by calorimetry

Secondary Outcomes

  • Change of Carbon dioxide production (VCO2) from baseline and interventions.(VCO2 will be taken during the each intervention, it will be taken only the first day)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ada Clarice Gastaldi

Principal Investigator

University of Sao Paulo

Study Sites (1)

Loading locations...

Similar Trials